A mother who was negligently told to stop taking her anti-rejection tablets died after her pancreas failed. Her daughter has settled her medical negligence claim against the defendant trust.
Timeline of events
2010
In her late 30s, Sophie underwent a double kidney and pancreas transplant as a result of MELAS – a mitochondrial disease that affects the nervous system and muscles. She was advised to take anti-rejection tablets from thereon.
2021
Sophie visited the renal transplant clinic at the defendant trust, where she was advised to reduce her anti-rejection medication for four weeks and then to stop taking it. She was discharged from the clinic.
Sophie followed the advice given to her by the medical practitioners, and her health declined considerably, which resulted in multiple hospital admissions. Her pancreas became rejected and was removed.
2022
Sophie’s condition did not improve and she died at the age of 49.
How we helped Sophie’s case
Following her mother’s death, Sophie’s daughter approached us with her claim. We issued a letter of claim and the trust subsequently admitted liability and that the negligence contributed to Sophie’s death.
We then prepared a detailed schedule of loss and quantified the case. An out-of-court settlement and apology were secured.
A note from James Anderson
“Sophie was negligently told to stop her anti-rejection medication, which resulted in her pancreas transplant failing. For the next 12 months, she endured terrible pain and suffering and, heartbreakingly, died a few days before her 50th birthday. This could all have been avoided if she had not been told to reduce and then stop taking her anti-rejection medication.”
